Adaptive Biotechnologies Corp — Director's Dealing 2020

Jan 8, 2020

SEC Form 4/A — Form 4/A

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2019-12-26

Reporting Person: DOBMEIER ERIC (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-26	Common Stock	M	15000	$6.32	Acquired	15000	Direct
2019-12-26	Common Stock	S	14998	$29.29	Disposed	2	Direct
2019-12-26	Common Stock	S	2	$29.91	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-26	Stock Option (Right to Buy)	$6.32	M	15000	Disposed	2026-10-18	Common Stock (15000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2019.

F2: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $28.85 to 29.73, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.

F3: The options vested with respect to 1/4 of the reporting person's shares on September 28, 2017, with an additional 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.